{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:59Z","timestamp":1789913219353,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00417-014-2803-3","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T12:39:59Z","timestamp":1410957599000},"page":"1999-2003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mycobacterium w administration for steroid resistant optic neuritis with long-term follow-up"],"prefix":"10.1007","volume":"252","author":[{"given":"Aditya","family":"Sudhalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakulesh","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"issue":"11","key":"2803_CR1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","volume":"15","author":"A Tselis","year":"2008","unstructured":"Tselis A, Perumal J, Caon C, Hreha S, Ching W, Din M, Van Stavern G, Khan O (2008) Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur J Neurol 15(11):1163\u20137","journal-title":"Eur J Neurol"},{"issue":"11","key":"2803_CR2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1468-1331.2008.02257.x","volume":"15","author":"A Achiron","year":"2008","unstructured":"Achiron A (2008) Winning combination: the additive\/synergistic benefits of IVIg in corticosteroid refractory optic neuritis. Eur J Neurol 15(11):1145","journal-title":"Eur J Neurol"},{"issue":"Suppl I","key":"2803_CR3","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s10067-010-1561-9","volume":"32","author":"C Huchzermeyer","year":"2013","unstructured":"Huchzermeyer C, Mardin C, Holbach L, Zwerina J, Schett G, Rech J (2013) Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener\u2019s granulomatosis. Clin Rheumatol 32(Suppl I):S97\u2013101","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2803_CR4","first-page":"172","volume":"35","author":"CC Mok","year":"2008","unstructured":"Mok CC, To CH, Mak A, Poon WL (2008) Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica. J Rheumatol 35(1):172\u20134","journal-title":"J Rheumatol"},{"issue":"1","key":"2803_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(98)00372-6","volume":"106","author":"G Galindo-Rodr\u00edguez","year":"1999","unstructured":"Galindo-Rodr\u00edguez G, Avi\u00f1a-Zubieta JA, Pizarro S, D\u00edaz de Le\u00f3n V, Saucedo N, Fuentes M, Lavalle C (1999) Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. Am J Med 106(1):65\u20139","journal-title":"Am J Med"},{"issue":"9","key":"2803_CR6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","volume":"66","author":"A Jacob","year":"2009","unstructured":"Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ (2009) Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 66(9):1128\u201333","journal-title":"Arch Neurol"},{"issue":"5","key":"2803_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jca.20298","volume":"26","author":"K Gwathmey","year":"2011","unstructured":"Gwathmey K, Balogun RA, Burns T (2011) Neurologic indications for therapeutic plasma exchange: an update. J Clin Apher 26(5):261\u2013268","journal-title":"J Clin Apher"},{"issue":"1","key":"2803_CR8","first-page":"56","volume":"3","author":"P Bronzlik","year":"2011","unstructured":"Bronzlik P, Toto S, Kielstein JT, Schmidt BMW, Stangel M, Trebst C (2011) Therapeutic plasma exchange and immunoadsorption therapy in neurological diseases. Eur J Neurol 3(1):56\u201361","journal-title":"Eur J Neurol"},{"issue":"2","key":"2803_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","volume":"28","author":"C Trebst","year":"2009","unstructured":"Trebst C, Reising A, Kielstein JT, Hafer C, Stangel M (2009) Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 28(2):108\u2013115","journal-title":"Blood Purif"},{"issue":"2","key":"2803_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2011.01612.x","volume":"126","author":"S Roesner","year":"2012","unstructured":"Roesner S, Appel R, Gbadamosi J, Martin R, Heesen C (2012) Treatment of steroid-unresponsive optic neuritis with plasma exchange. Acta Neurol Scand 126(2):103\u20138","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2803_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","volume":"9","author":"MJ Koziolek","year":"2012","unstructured":"Koziolek MJ, Tampe D, Bahr M, Dihazi H, Jung K, Fitzner D, Klingel R, Miller G, Kitze B (2012) Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis. J Neuroinflammation 9(1):80","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2803_CR12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00417-011-1896-1","volume":"250","author":"A Sudhalkar","year":"2012","unstructured":"Sudhalkar A, Khamar M, Khamar B (2012) Outcomes of toll-like receptors\u2019 antagonism in steroid-resistant optic neuritis; a pilot study. Graefes Arch Clin Exp Ophthalmol 250(6):871\u20137","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"2803_CR13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ana.22136","volume":"68","author":"KE Balashov","year":"2010","unstructured":"Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL (2010) Interferon-\u03b2 inhibits toll-like receptor 9 processing in multiple sclerosis. Ann Neurol 68(6):899\u2013906","journal-title":"Ann Neurol"},{"key":"2803_CR14","volume-title":"Albert and Jackobiec\u2019s principles and practice of ophthalmology","author":"D Albert","year":"2008","unstructured":"Albert D, Azar D, Blodi B, Miller J (2008) Albert and Jackobiec\u2019s principles and practice of ophthalmology, 3rd edn. Saunders\u2013Elsevier, Philadelphia","edition":"3"},{"key":"2803_CR15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2147\/OPTH.S28112","volume":"6","author":"H Pula","year":"2012","unstructured":"Pula H, MacDonald C (2012) Current options for the treatment of optic neuritis. Clin Ophthalmol 6:1211\u20131223","journal-title":"Clin Ophthalmol"},{"key":"2803_CR16","volume-title":"The chemotherapy source book","author":"E Perry","year":"2007","unstructured":"Perry E (2007) The chemotherapy source book, 4th edn. Lippincott, Williams and Wilkins, Philadelphia","edition":"4"},{"issue":"9","key":"2803_CR17","first-page":"559","volume":"101","author":"P Chaudhari","year":"2003","unstructured":"Chaudhari P, Mukhopadhyaya S (2003) Bladder preserving approach for muscle invasive bladder cancer-role of mycobacterium w. J Indian Med Assoc 101(9):559\u201360","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"2803_CR18","first-page":"174","volume":"70","author":"I Kaur","year":"2002","unstructured":"Kaur I, Dogra S, Kumar B, Radotra V (2002) Combined 12-month WHO\/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Int J Lepr Other Mycobact Dis 70(3):174\u201381","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"2803_CR19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2005.06343.x","volume":"152","author":"B Kumar","year":"2005","unstructured":"Kumar B, Sandhu K, Kaur I (2005) Role of Mycobacterium w vaccine in the management of psoriasis. Br J Dermatol 152:368\u2013403","journal-title":"Br J Dermatol"},{"issue":"16S Part 1","key":"2803_CR20","first-page":"521 s","volume":"23","author":"S Sarkar","year":"2005","unstructured":"Sarkar S, Dasgupta C (2005) Role of Mycobacterium W as an adjuvant treatment of head & neck cancer: a randomised trial. J Clin Oncol 23(16S Part 1):521 s","journal-title":"J Clin Oncol"},{"issue":"9","key":"2803_CR21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, Savino P, Guy J, Trobe J, McCrary-III J, Smith C, Chrousos G, Thompson SH, Katz B, Brodsky MC, Goodwin JA, Atwell CW, The Optic Neuritis Study Group (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326(9):581\u2013588","journal-title":"N Engl J Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2803-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2803-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:45Z","timestamp":1559058045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2803-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2803-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}